Conventional trials to test coronavirus vaccines are paradoxically slowed down by actions to curb the disease’s spread. Human challenge trials are more controversial, but could speed up the process.
Academic rigour, journalistic flair
Articles on Vaccine trials
Displaying 21 - 29 of 29 articles
There isn’t enough clinical research being done in Africa. This has had a lot of repercussions in terms of the timing when interventions become available and effective in high income countries.
Early clinical trials into ginseng, rhubarb and rice paved the way for testing coronavirus treatments today.
Army physicians are turning to drugs approved for other conditions or newly developed treatments such as the antiviral Remdesivir to treat infected personnel.
Researchers around the world are working hard on developing a vaccine – but the process may still take 12-18 months. Here’s why.
Four new Ebola treatments are being tried out in the DRC.
Speaking on the ABC program Insiders, One Nation leader Pauline Hanson suggested there are tests available to see if children will have an adverse reaction to vaccinations. We asked three experts.
For the next five years South Africa will be leading one of the latest large-scale trials for a vaccine for HIV.
Two major clinical trials will be conducted in South Africa in 2016 to test ways of preventing new HIV infections.
Job Board
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
-
Technical Skills Laboratory Officer
-
Faculty of Law - Academic Appointment Opportunities
-
Audience Development Coordinator (fixed-term maternity cover)
Top contributors
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor of medicine, epidemiology & biostatistics, and philosophy, Western University
-
Research Professor and DST/NRF SARChI Chair of Virus-Host Dynamics, National Institute for Communicable Diseases, CAPRISA Research Associate, University of the Witwatersrand
-
Associate Professor of Marketing, University of Technology Sydney
-
Medical Scientist at the National Institute for Communicable Diseases; Research Associate at CAPRISA; Research Professor in the School of Pathology, University of the Witwatersrand
-
Infectious Disease Ethics Fellow, Ethox & Wellcome Centre for Ethics and Humanities, Univeristy of Oxford. Adjunct, Monash University
-
Professor of Bioethics, Monash Bioethics Centre, Monash University, Monash University
-
Senior Research Officer, Telethon Kids Institute
-
Associate Professor, University of Oxford
-
Professor of Paediatric Infection and Immunity, University of Oxford
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Medical Scientist, National Institute for Communicable Diseases
